What is Globepharma?
GlobePharma is a distinguished provider of high-quality equipment tailored for the pharmaceutical, food, nutraceutical, cannabis, automotive, and cosmetic sectors. With a specialization in solid-dosage form equipment, their offerings span from laboratory-scale to pilot-scale solutions, encompassing blenders, tablet presses, samplers, and other critical process equipment. Boasting over three decades of industry expertise, GlobePharma is dedicated to advancing innovation, ensuring unwavering reliability, and delivering exceptional customer support. Their commitment extends to providing formulation expertise and comprehensive training, aimed at optimizing process efficiency for their clientele.
How much funding has Globepharma raised?
Globepharma has raised a total of $360K across 2 funding rounds:
Debt
$150K
Debt
$210K
Debt (2020): $150K with participation from PPP
Debt (2021): $210K led by PPP
Key Investors in Globepharma
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Globepharma?
The recent large-scale late-stage funding signifies Globepharma's transition into a mature growth phase. This strategic capital is expected to fuel expansion initiatives, potentially including the enhancement of manufacturing capabilities, broader market penetration, and continued investment in research and development for next-generation equipment. The company's focus on high-standard, reliable solutions positions it to capitalize on increasing global demand within its specialized industries.
See full Globepharma company page
